Cargando…
Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization
The presence of anti-HLA antibodies is an increasing challenge in kidney transplantation. Tocilizumab (TCZ), a monoclonal antibody targeting the interleukin-6 receptor (IL-6R), has been proposed to complement conventional desensitization therapy. We aimed to describe TCZ plasma trough concentrations...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745611/ https://www.ncbi.nlm.nih.gov/pubmed/35011830 http://dx.doi.org/10.3390/jcm11010091 |